Inventor · disambiguated record
Charles Huang
Also filed as: HUANG CHARLES · HUANG CHARLES Q
19 granted patents·6 pending applications·309 citations·filing 1996–2007
95Inventor score
Top patents by PatentIndex Score
25 records- 0195US7419983B2Gonadotropin-releasing hormone receptor antagonists and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2007·Granted Sep 2, 2008·38 cites·40 claims
- 0294US7176211B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2005·Granted Feb 13, 2007·32 cites·20 claims
- 0393US7056927B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Granted Jun 6, 2006·49 cites·45 claims
- 0490US6531475B1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2000·Granted Mar 11, 2003·38 cites·44 claims
- 0587US7229995B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2005·Granted Jun 12, 2007·10 cites·20 claims
- 0684US6664261B2Pyrazolopyrimidines as CRF receptor antagonistsNEUROCRINE BIOSCIENCES INC·Filed 1997·Granted Dec 16, 2003·28 cites·14 claims
- 0783US5959109ACompounds and methods for increasing endogenous levels of corticotropin-releasing factorNEUROCRINE BIOSCIENCES INC·Filed 1996·Granted Sep 28, 1999·28 cites·18 claims
- 0880US7015226B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Granted Mar 21, 2006·12 cites·28 claims
- 0979US6610678B2CRF antagonistic quino-and quinazolinesFiled 2002·Granted Aug 26, 2003·11 cites·13 claims
- 1077US7074797B2Pyrazolopyrimidines as CRF receptor antagonistsNEUROCRINE BIOSCIENCES INC·Filed 2003·Granted Jul 11, 2006·6 cites·17 claims
- 1175US7329669B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2006·Granted Feb 12, 2008·2 cites·20 claims
- 1273US7071200B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Granted Jul 4, 2006·6 cites·39 claims
- 1372US6747034B2CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2001·Granted Jun 8, 2004·5 cites·31 claims
- 1470US6133276ACompounds and methods for increasing endogenous levels of corticotropin-releasing factorNEUROCRINE BIOSCIENCES INC·Filed 1998·Granted Oct 17, 2000·12 cites·65 claims
- 1566US7276610B2Aryl piperidine amidesJANSSEN PHARACEUTICA NV·Filed 2004·Granted Oct 2, 2007·5 cites·7 claims
- 1661US6514982B1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 1999·Granted Feb 4, 2003·19 cites·32 claims
- 1760US2006270659A1Pyrazolopyrimidines as CRF receptor antagonistsNEUROCRINE BIOSCIENCES INC·Filed 2006·Application pending·0 cites
- 1855US7915420B2Aryl piperidine amidesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Mar 29, 2011·0 cites·6 claims
- 1953US2004157851A1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
- 2053US2004121998A1CRF antagonistic quino- and quinazolinesNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
- 2152US2004266799A1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 2251US2004087589A1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
- 2347US6613777B1CRF antagonistic pyrazolo[4,3-b]pyridinesFiled 1999·Granted Sep 2, 2003·4 cites·15 claims
- 2445US2004121999A1CRF antagonistic pyrazolo[4,3-b]pyridinesNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
- 2543US6482836B1CRF antagonistic quino- and quinazolinesFiled 1998·Granted Nov 19, 2002·4 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Charles Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →